ArticleNPJ breast cancer2025

Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.

Javier Cortes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.